Related Experiment Video
Updated: Jan 28, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
No Difference in Behavioral and Self-Reported Outcomes for Simultaneous and Sequential Bilateral Cochlear
Véronique J C Kraaijenga1,2, Geerte G J Ramakers1,2, Yvette E Smulders1,2,3
1Department of Otorhinolaryngology - Head and Neck Surgery, University Medical Center Utrecht, Utrecht, Netherlands.
Simultaneous bilateral cochlear implantation (simBiCI) offers superior long-term outcomes in speech perception and localization compared to sequential bilateral cochlear implantation (seqBiCI). However, seqBiCI outcomes improve to match simBiCI after the second implant is activated.
Area of Science:
- Audiology
- Neuroscience
- Otolaryngology
Background:
- Severe-to-profound postlingual sensorineural hearing loss impacts quality of life.
- Bilateral cochlear implantation (BiCI) aims to restore hearing in both ears.
- Simultaneous (simBiCI) and sequential (seqBiCI) approaches exist, with differing outcomes.
Purpose of the Study:
- To longitudinally compare behavioral and self-reported outcomes of simBiCI versus seqBiCI in adults.
- To assess speech perception in noise, localization, and quality of life.
- To evaluate outcomes over a 4-year follow-up period.
Main Methods:
- Multicenter randomized controlled trial with 4-year follow-up.
- Adults with severe-to-profound hearing loss randomized to simBiCI or seqBiCI (2-year interval).
- Annual assessments of speech perception (in quiet and noise), localization, quality of life, and hearing questionnaires.
Main Results:
- Both groups performed equally on speech perception in noise directly in front.
- SeqBiCI group showed significantly worse spatial speech perception and localization during unilateral use.
- SeqBiCI outcomes matched simBiCI after the second cochlear implant activation; no differences in tinnitus.
- Complications included infection, CI dysfunction, facial nerve palsy, tinnitus, and vertigo.
Conclusions:
- SimBiCI demonstrates superior longitudinal performance in spatial speech perception and localization compared to seqBiCI.
- The initial performance gap in seqBiCI is attributed to the period of unilateral cochlear implant use.
- Full bilateral benefit is achieved in seqBiCI once the second implant is activated, matching simBiCI outcomes.
Related Concept Videos
The Evidence for Evolution
Clinical Trials: Overview
Trial and Error and Algorithm
Clinical Trials
There are four phases in a clinical trial. A phase one...
Data Reporting and Recording
Random Error

